The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis

被引:161
|
作者
Manoury, B
Nenan, S
Leclerc, O
Guenon, I
Boichot, E
Planquois, JM
Bertrand, CP
Lagente, V [1 ]
机构
[1] Univ Rennes 1, Lab Pharmacodynamie & Pharmacol Mol, INSERM, U620, Rennes, France
[2] Pfizer Global R&D, Fresnes Labs, Fresnes, France
关键词
D O I
10.1186/1465-9921-6-11
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Reactive oxygen species and tissue remodeling regulators, such as metalloproteinases (MMPs) and their inhibitors (TIMPs), are thought to be involved in the development of pulmonary fibrosis. We investigated these factors in the fibrotic response to bleomycin of p47(phox)-/- (KO) mice, deficient for ROS production through the NADPH-oxidase pathway. Methods: Mice are administered by intranasal instillation of 0.1 mg bleomycin. Either 24 h or 14 days after, mice were anesthetized and underwent either bronchoalveolar lavage (BAL) or lung removal. Results: BAL cells from bleomycin treated WT mice showed enhanced ROS production after PMA stimulation, whereas no change was observed with BAL cells from p47(phox)-/- mice. At day 1, the bleomycin-induced acute inflammatory response (increased neutrophil count and MMP-9 activity in the BAL fluid) was strikingly greater in KO than wild-type (WT) mice, while IL-6 levels increased significantly more in the latter. Hydroxyproline assays in the lung tissue 14 days after bleomycin administration revealed the absence of collagen deposition in the lungs of the KO mice, which had significantly lower hydroxyproline levels than the WT mice. The MMP-9/TIMP-1 ratio did not change at day 1 after bleomycin administration in WT mice, but increased significantly in the KO mice. By day 14, the ratio fell significantly from baseline in both strains, but more in the WT than KO strains. Conclusions: These results suggest that NADPH-oxidase-derived ROS are essential to the development of pulmonary fibrosis. The absence of collagen deposition in KO mice seems to be associated with an elevated MMP-9/TIMP-1 ratio in the lungs. This finding highlights the importance of metalloproteinases and protease/anti-protease imbalances in pulmonary fibrosis.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] MELATONIN ALLEVIATES BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN MICE
    Karimfar, M. H.
    Rostami, S.
    Haghani, K.
    Bakhtiyari, S.
    Noori-Zadeh, A.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2015, 29 (02): : 327 - 334
  • [42] Liver damage in bleomycin-induced pulmonary fibrosis in mice
    V. R. Vásquez-Garzón
    A. Ramírez-Cosmes
    E. Reyes-Jiménez
    G. Carrasco-Torres
    S. Hernández-García
    S. R. Aguilar-Ruiz
    H. Torres-Aguilar
    J. Alpuche
    L. Pérez-Campos Mayoral
    S. Pina-Canseco
    J. Arellanes-Robledo
    S. Villa-Treviño
    R. Baltiérrez-Hoyos
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, 392 : 1503 - 1513
  • [43] Dasatinib attenuated bleomycin-induced pulmonary fibrosis in mice
    Yilmaz, Oznur
    Oztay, Fusun
    Kayalar, Ozgecan
    GROWTH FACTORS, 2015, 33 (5-6) : 366 - 375
  • [44] Liver damage in bleomycin-induced pulmonary fibrosis in mice
    Vasquez-Garzon, V. R.
    Ramirez-Cosmes, A.
    Reyes-Jimenez, E.
    Carrasco-Torres, G.
    Hernandez-Garcia, S.
    Aguilar-Ruiz, S. R.
    Torres-Aguilar, H.
    Alpuche, J.
    Mayoral, L. Perez-Campos
    Pina-Canseco, S.
    Arellanes-Robledo, J.
    Villa-Trevino, S.
    Baltierrez-Hoyos, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 (12) : 1503 - 1513
  • [45] Mefunidone Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
    Han, Yuanyuan
    Jiang, Mao
    He, Rongling
    Lv, Xin
    Liao, Xiaohua
    He, Yijun
    Zhang, Fan
    Long, Lingzhi
    Jiang, Guoliang
    Peng, Zhangzhe
    Tao, Lijian
    Hu, Gaoyun
    Meng, Jie
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [46] EETs inhibits the bleomycin-induced pulmonary fibrosis in mice
    Zhou, Hui-Fang
    Zhou, Yong
    Sun, Guo-Ying
    Xie, Hui
    Chen, Li-Yu
    Peng, Li
    Guan, Cha-Xiang
    REGULATORY PEPTIDES, 2012, 177 : S36 - S37
  • [47] Vagotomy attenuates bleomycin-induced pulmonary fibrosis in mice
    Nana Song
    Jun Liu
    Saad Shaheen
    Lei Du
    Mary Proctor
    Jesse Roman
    Jerry Yu
    Scientific Reports, 5
  • [48] Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice
    Tabata, Chiharu
    Tabata, Rie
    Kadokawa, Yoshio
    Hisamori, Shigeo
    Takahashi, Meiko
    Mishima, Michiaki
    Nakano, Takashi
    Kubo, Hajime
    JOURNAL OF IMMUNOLOGY, 2007, 179 (01): : 708 - 714
  • [49] Elastase modifies bleomycin-induced pulmonary fibrosis in mice
    Silva Neto Trajano, Larissa Alexsandra
    Lima Trajano, Eduardo Tavares
    Lanzetti, Manuella
    Amorim Mendonca, Morena Scopel
    Guilherme, Rafael Freitas
    Figueiredo, Rodrigo Tinoco
    Benjamim, Claudia Farias
    Valenca, Samuel Santos
    Alto Costa, Andrea Monte
    Porto, Luis Cristovao
    ACTA HISTOCHEMICA, 2016, 118 (03) : 203 - 212
  • [50] Paeoniflorin attenuates bleomycin-induced pulmonary fibrosis in mice
    Wu, Xin
    Ji, Yu
    Dai, Yue
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 32 - 32